Abide Care Limited 07368127 true 2023-10-01 2024-09-30 2024-09-30 The principal activity of the company is the selling and distribution of health related products. Digita Accounts Production Advanced 6.30.9574.0 true D B K Afeeva true 07368127 2023-10-01 2024-09-30 07368127 2024-09-30 07368127 core:RetainedEarningsAccumulatedLosses 2024-09-30 07368127 core:ShareCapital 2024-09-30 07368127 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 07368127 core:OtherPropertyPlantEquipment 2024-09-30 07368127 bus:FRS102 2023-10-01 2024-09-30 07368127 bus:AuditExempt-NoAccountantsReport 2023-10-01 2024-09-30 07368127 bus:FullAccounts 2023-10-01 2024-09-30 07368127 bus:RegisteredOffice 2023-10-01 2024-09-30 07368127 bus:Director1 2023-10-01 2024-09-30 07368127 bus:EntityNoLongerTradingButTradedInPast 2023-10-01 2024-09-30 07368127 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 07368127 core:ComputerEquipment 2023-10-01 2024-09-30 07368127 countries:EnglandWales 2023-10-01 2024-09-30 07368127 core:OtherPropertyPlantEquipment 2023-09-30 07368127 2023-09-30 07368127 core:RetainedEarningsAccumulatedLosses 2023-09-30 07368127 core:ShareCapital 2023-09-30 07368127 core:CurrentFinancialInstruments core:WithinOneYear 2023-09-30 07368127 core:OtherPropertyPlantEquipment 2023-09-30 iso4217:GBP

Registration number: 07368127

Abide Care Limited
Annual Report and Unaudited Financial Statements
for the Year Ended 30 September 2024

Abide Care Limited

Company Information

Director | D B K Afeeva

Registered office | 90 Dorville Road Lee London SE12 8DR

Accountants | Hazlewoods LLP Windsor House Bayshill Road Cheltenham GL50 3AT

Abide Care Limited

(Registration number: 07368127)
Balance Sheet as at 30 September 2024

| Note | 2024 £ | 2023 £
Fixed assets |  |  |
Tangible assets | 4 | 924 | 924
Creditors: Amounts falling due within one year | 5 | (73,677) | (73,677)
Net liabilities |  | (72,753) | (72,753)
Capital and reserves |  |  |
Called up share capital |  | 1 | 1
Retained earnings |  | (72,754) | (72,754)
Shareholders' deficit |  | (72,753) | (72,753)

For the financial year ending 30 September 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the director on 20 June 2025

D B K Afeeva
Director

Abide Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
90 Dorville Road
Lee
London
SE12 8DR

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Judgements

These financial statements do not contain any significant judgements or estimation uncertainty.

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies..

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Computer equipment | 30% reducing balance

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Abide Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

Financial instruments

Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.
Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.
Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.
A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.
The recoverable amount of goodwill is derived from measurement of the present value of the future cash flows of the cash-generating units ('CGUs') of which the goodwill is a part. Any impairment loss in respect of a CGU is allocated first to the goodwill attached to that CGU, and then to other assets within that CGU on a pro-rata basis.
Where indicators exist for a decrease in impairment loss, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised. Where a reversal of impairment occurs in respect of a CGU, the reversal is applied first to the assets (other than goodwill) of the CGU on a pro-rata basis and then to any goodwill allocated to that CGU.
For financial assets carried at amortised cost, the amount of an impairment is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.
For financial assets carried at cost less impairment, the impairment loss is the difference between the asset’s carrying amount and the best estimate of the amount that would be received for the asset if it were to be sold at the reporting date.
Where indicators exist for a decrease in impairment loss, and the decrease can be related objectively to an event occurring after the impairment was recognised, the prior impairment loss is tested to determine reversal. An impairment loss is reversed on an individual impaired financial asset to the extent that the revised recoverable value does not lead to a revised carrying amount higher than the carrying value had no impairment been recognised.

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

| 2024 No. | 2023 No.
Average number of employees | 1 | 1

Abide Care Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2024

4 | Tangible assets

| Computer equipment £
Cost or valuation
At 1 October 2023 and 30 September 2024 | 3,403
Depreciation
At 1 October 2023 | 2,479
At 30 September 2024 | 2,479
Carrying amount
At 30 September 2024 | 924
At 30 September 2023 | 924

5 | Creditors

| 2024 £ | 2023 £
Due within one year |  |
Other payables | 73,677 | 73,677